The influence of aging on the pharmacodynamics of anaesthetic agents in the central nervous system remains poorly understood. As ␣-aminobutyric acid (GABA)-mediated neurotransmission appears to be an important target for anaesthetics in the brain, we hypothesized that aging could alter the sensitivity of the GABA carrier to anaesthetics. We have examined the effects of etomidate and propofol on the uptake of [ 3 H]-GABA (5 min, 37 ЊC)
Subjects aged 75 yr or more represent a growing subpopulation of surgical patients. The perioperative management of these patients has to deal with physiological, pharmacological and psychological changes associated with aging, which represent risk factors for concomitant disease and death. 1 Several lines of evidence suggest that aging may induce alterations in the pharmacodynamics of anaesthetic agents in the CNS. Indeed, sensitivity to the hypnotic effects of midazolam is increased in elderly surgical patients, independent of pharmacokinetic phenomena. 2 Also, the alteration of psychomotor functions observed at emergence from propofol anaesthesia in surgical patients aged 70 or more is likely to be mediated in part via pharmacodynamic mechanisms. 3 We have recently shown that some i.v. anaesthetics inhibit the reuptake of GABA in a reversible fashion in vitro. 4 This might contribute to the production of unconsciousness in vivo. Therefore, in the present study, we have examined the effect of aging on the sensitivity of the GABA carrier to etomidate and propofol in a preparation of striatal synaptosomes (pinched-off nerve endings) in vitro.
Methods and results
Handling procedures, as written in the Guide for the Care and Use of Laboratory Animals, were followed throughout. Experiments were performed on male ). Etomidate and propofol were dissolved in dimethylsulphoxide (Merck, Germany). After 5-min incubation, the mixture was vacuum filtered through glass filters (Whatman, GF/F, 0.70-m retention capacity) and washed with 10 ml of ice-cold CSF. The radioactivity retained on the filters was extracted with NaOH 0.1 mol litre 91 and measured by liquid scintillation in Aquasol 2 (New England Nuclear, USA). Specific ) as previously reported. 4 The reaction was stopped by addition of ice-cold CSF followed by vacuum filtration, and the radioactivity retained on the filters measured. Kinetic variables of the reaction (maximum velocity, Vmax; MichaelisMenton constant, K m ) were determined by genera- There was a significant increase in the values for IC 50 of both propofol and etomidate in the 24-monthold rats. This value was found significantly increased for propofol, but not etomidate, in the 18-month-old animals. No significant change in the inhibitory effect of nipecotic acid was observed whichever the subpopulation of rats examined.
Comment
This study shows for the first time that aging induces functional alterations of neurotransmitters relevant to anaesthesia and subsequently produces changes in the pharmacodynamics of anaesthetics in the CNS. Indeed, the sensitivity of the GABA carrier to propofol and etomidate, two agents currently used, is decreased in old compared with young rats, as assessed by a significant increase in the IC 50 values for propofol (at 18 and 24 months) and etomidate (at 24 months). The IC 50 values reported here for the inhibition of GABA uptake by nipecotic acid, propofol and etomidate and the kinetic analysis of this inhibition are consistent with our previous results. 4 These anaesthetic concentrations are slightly greater than those required to produce anaesthesia. 5 However, they can be considered clinically relevant, because they are in the range of those found in the plasma of anaesthetized humans. 6 7 Therefore, the present data confirm and extend the observation that propofol and etomidate inhibit the activity of the GABA carrier in a non-competitive fashion.
The mechanisms underlying the aging-related decrease in sensitivity to propofol and etomidate remain to be elucidated. An aging-related neuronal loss has been reported in some species, but the functional relevance of this phenomenon remains controversial. 8 Whether anaesthetics interact via the lipid environment of the GABA carrier or directly with the protein cannot be inferred from our data. Interestingly, and in contrast with propofol and etomidate, the potency of nipecotic acid to block GABA uptake was not affected by aging. Therefore, it is likely that propofol and etomidate do not share the same mechanism for blocking GABA uptake as nipecotic acid, and that aging selectively affects the anaesthetic-carrier interaction.
A major consequence of blocking GABA uptake is to increase the background levels of GABA activating extrasynaptic GABA A or even GABA B -mediated synaptic transmission. This may contribute to the production of the anaesthetic state. The clinical relevance of the aging-related decrease in sensitivity to propofol and etomidate of the GABA carrier remains to be determined. It can be speculated that these or other related pharmacodynamic changes might contribute to the modifications in anaesthetic requirements that are observed in the elderly. 
